A liquid formulation of L-thyroxine (L-T4) solves problems of incomplete normalization/suppression of serum TSH caused by proton pump inhibitors (PPI) on conventional tablet formulations of L-T4
Year: 2012
Type: article
Authors: G. Ezequiel Saraceno, Raffaella De Vita, Francesco Trimarchi, Salvatore Benvenga
Language: English
Subfield: Endocrinology, Diabetes and Metabolism
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W2234227560